While the IL-15/mammalian target of rapamycin (mTOR) and type I interferon (IFN) signaling pathways were constitutively active in NK cells purified from the leukemia murine model, these cells could not respond to stimulation with IL-15, in vitro. This evidence concerns the gene IL15 and leukemia.